General news

Third quarter 2024 sales update

Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the third quarter of 2024 (the three months ended 30 September 2024).

Half year 2024 results

Group performance in line with expectations reflecting more stable market conditions and operational progress

First quarter 2024 sales update

Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the first quarter of 2024 (the three months ended 31 March 2024).

Full year results announcement 2023

27 February 2024: Croda International Plc today announce their full year results for year ending 31 December 2023.

Croda breaks ground at new Consumer Care production facility in China

27 October 2023: Croda breaks ground at new Consumer Care production facility in China

Third quarter trading update

Update on trading from 01 July to 30 September 2023

Croda’s first product launch specifically focusing on the biopesticide market

28 September 2023: Croda has launched the new product Atlox™ BS-50, a delivery system which specifically meets the needs of the growing biopesticide market.

Croda introduces new bioprocessing solutions to replace banned materials

30 August 2023: Croda has introduced a range of new bioprocessing aids called Virodex™.

Half year 2023 results

Continued investment and strategic progress despite a challenging environment.

Croda announces Global Technical Centre in Hyderabad

5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.

Trading update

Update on trading for the period ending 31 May 2023.

Croda breaks ground on new manufacturing facility for pharmaceutical excipients

5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.

Full year 2022 results

Powerful operating model and consistent execution delivers record performance.

Pharma investor seminar

Empowering biologics delivery in Pharma

Launch of first report on biotechnology opportunities in the personal care market

27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...

Excellent first half performance driving profit growth

Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company

Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...

Croda Pharma wins prestigious award

6 May 2022: Croda Pharma was awarded ''Best Supplier for COVID-19 Vaccine Development” at the India Biologics & Vaccines Outstanding Industry Awards (BVOIA) 2022.